相关实验视频

Updated: Jul 5, 2025

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Published on: September 26, 2016

超越边界:揭开与骨转移性癌症作斗争的创新方法

Huanrong Lan¹, Bo Wu¹, Ketao Jin²

¹Department of Surgical Oncology, Hangzhou Cancer Hospital, Hangzhou, Zhejiang, China.

Frontiers in endocrinology

|January 23, 2024

概括

骨转移是癌症的常见和严重并发症,特别是前列腺癌和乳腺癌. 了解瘤细胞与骨微环境 (BME) 的相互作用,对于开发更好的治疗方法至关重要.

科学领域:

在瘤学瘤学.
癌症生物学癌症生物学
骨生物学骨生物学

背景情况:

骨转移是晚期癌症,特别是前列腺癌和乳腺癌的常见并发症,严重影响患者的预后.
骨微环境 (BME) 在支持瘤细胞生存和进展方面发挥着关键作用.
目前治疗骨转移的疗法效果有限,重点是抑制而不是治愈.

研究的目的:

审查驱动骨转移的机制.
讨论骨转移的临床影响.
突出针对骨转移性癌症的新型治疗策略.

主要方法:

文献综述综合了有关骨转移的当前研究.
分析瘤细胞与骨微环境之间的相互作用.
检查临床方面和新兴治疗方法.

主要成果:

骨转移是一个复杂的过程,涉及到BME内部的复杂相互作用.
骨转移患者的预后仍然很差,治疗选择有限.
新兴疗法在治疗骨转移和改善患者生活质量方面表现有前途.

结论:

更深入地了解瘤-BME相互作用对于推进骨转移研究至关重要.
需要创新的诊断和治疗策略来改善骨转移患者的治疗结果.
本综述提供了有关管理骨转移的当前挑战和未来方向的见解.

关键词:

骨微环境是一个微环境.骨头改造骨头改造骨头改造癌症癌症癌症癌症转移转移转移转移与治疗相关的新生体.

更多相关视频

Models of Bone Metastasis

Models of Bone Metastasis

Published on: September 4, 2012

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...